SVP and Chief Technical Officer Michael J. Labarre sold $1.8M of Halozyme Therapeutics, Inc.

Sold$1,842,315

$45.70Price

40,315Shares

−23%Stake

What HALO did after the filing

Prices for HALO after this filing aren't in yet.

Traded Thu, Jul 1. Filed Tue, Jul 6, 1:19 PM ET, during the session. Not investment advice.